Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1016/s1473-3099(19)30035-0

Type

Journal article

Journal

The Lancet. Infectious Diseases

Publication Date

03/2019

Volume

19

Pages

218 - 219

Addresses

Eijkman-Oxford Clinical Research Unit, Eijkman Institute for Molecular Biology, and Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands. Electronic address: raph.hamers@ndm.ox.ac.uk.

Keywords

Humans, HIV-1, HIV Infections, Ritonavir, Heterocyclic Compounds, 3-Ring, RNA-Directed DNA Polymerase, Adult, Lopinavir